These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16462666)

  • 1. [Thrombocytosis: adverse effect of heparin treatment].
    Camou F; Viallard JF; Caubet O; Pellegrin JL
    Presse Med; 2006 Jan; 35(1 Pt 1):58-60. PubMed ID: 16462666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-molecular-weight heparins and thrombocytosis.
    Liautard C; Nunes AM; Vial T; Chatillon F; Guy C; Ollagnier M; Descotes J
    Ann Pharmacother; 2002 Sep; 36(9):1351-4. PubMed ID: 12196050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enoxaparin induced reactive thrombocytosis: a rare adverse drug reaction.
    Meenpidiyil SS; Azeez S; Kumar VP; Suresh D; Kalathathoduuill S; Thandupara S; Puthukudi MH
    J Basic Clin Physiol Pharmacol; 2020 Jun; 31(5):. PubMed ID: 32589604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombocytosis after prophylactic administration of enoxaparin: unexpected findings in a Polish prospective multicenter trial on the efficacy and safety of enoxaparin in the prevention of postoperative thromboembolism.
    Ziaja K; Simka M; Krupowies A; Dugaj M; Ludyga T
    Int Angiol; 1999 Mar; 18(1):65-9. PubMed ID: 10392483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-molecular-weight heparin and thrombocytosis: a further reason to monitor the platelet count.
    Prescrire Int; 2003 Oct; 12(67):183. PubMed ID: 14619899
    [No Abstract]   [Full Text] [Related]  

  • 6. [Inappropriate prescription of heparin at curative doses in the hospital. Can the information to prescribing physicians decrease misuse?].
    Geffroy CE; Couffin E; Doucet J; Carvalho P; Sibert L; Bentot C; Mouton-Schleifer D; Lévesque H; Chassagne P; Bercoff E
    Presse Med; 2002 Feb; 31(7):303-11. PubMed ID: 11899684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombocytosis associated with low-molecular-weight heparin.
    Rizzieri DA; Wong WM; Gockerman JP
    Ann Intern Med; 1996 Jul; 125(2):157. PubMed ID: 8678382
    [No Abstract]   [Full Text] [Related]  

  • 8. Reactive thrombocytosis associated with enoxaparin.
    Hummel MC; Morse BC; Hayes LE
    Pharmacotherapy; 2006 Nov; 26(11):1667-70. PubMed ID: 17064215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombocytosis associated with low-molecular-weight heparin.
    Williams E
    Ann Intern Med; 1997 May; 126(9):742-3. PubMed ID: 9139569
    [No Abstract]   [Full Text] [Related]  

  • 10. Assessment of HIT antibody complex in hip fracture patients receiving enoxaparin or unfractionated heparin.
    Griffin JW; Hopkinson WJ; Lassen MR; Thethi I; Litinas E; Fareed J
    Clin Appl Thromb Hemost; 2011; 17(6):567-71. PubMed ID: 22345625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comment requested by the editorial staff].
    Haas S
    Chirurg; 2002 Dec; 73(12):1204. PubMed ID: 12617084
    [No Abstract]   [Full Text] [Related]  

  • 12. Dabigatran: new drug. Continue to use heparin, a better-known option.
    Prescrire Int; 2009 Jun; 18(101):97-9. PubMed ID: 19637411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Heparin induced thrombocytopenia type II after the use of low-molecular weight heparin. Case report and review of the literature].
    Franke J; Schaeper O; Kayser R; Mahlfeld K
    Unfallchirurg; 2003 Jan; 106(1):77-81. PubMed ID: 12552397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombocytosis associated with enoxaparin: A very rare cause in newborns.
    Tonbul A; Uras N; Tayman C; Halici T; Polat A; Mansur Tatli M
    Platelets; 2010; 21(4):300-2. PubMed ID: 20367573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Two surgical case reports showing atypical heparin-induced thrombocytopenia].
    Höhnke C; Haas S
    Chirurg; 2007 Feb; 78(2):138, 140-1. PubMed ID: 17252251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unfractionated heparin as a safe alternative in a case of low molecular weight heparin-induced thrombocytosis: A case report.
    Jabira S; Mitwally H; Saad M; Karic E; Gazwi K; Elzeer H; Elshafei M
    Ann Med Surg (Lond); 2021 May; 65():102370. PubMed ID: 34026103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Economic consequences of biological monitoring and medical complications of injectable anticoagulants in France].
    Paubel P; Cousin M; Amar C; Gourmelen J; Fabron C; Detournay B
    J Mal Vasc; 2016 Dec; 41(6):371-377. PubMed ID: 27817998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin-induced thrombocytopenia in patients with Philadelphia-negative myeloproliferative disorders and unusual splanchnic or cerebral vein thrombosis.
    Randi ML; Tezza F; Scapin M; Duner E; Scarparo P; Scandellari R; Fabris F
    Acta Haematol; 2010; 123(3):140-5. PubMed ID: 20134155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilisation and safety of low molecular weight heparins: prospective observational study in medical inpatients.
    Cestac P; Bagheri H; Lapeyre-Mestre M; Sié P; Fouladi A; Maupas E; Léger P; Fontan B; Massip P; Montastruc JL
    Drug Saf; 2003; 26(3):197-207. PubMed ID: 12580648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe bleeding associated with use of low molecular weight heparin and selective serotonin reuptake inhibitors.
    de Maistre E; Allart C; Lecompte T; Bollaert PE
    Am J Med; 2002 Oct; 113(6):530-2. PubMed ID: 12427509
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.